Manning & Napier Disciplined Value Z holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Manning & Napier Disciplined Value Series Class Z MDVZX
- NAV / 1-Day Return 9.78 / −0.71 %
- Total Assets 131.7M
-
Adj. Expense Ratio
0.460%
- Expense Ratio 0.450%
- Distribution Fee Level Low
- Share Class Type Institutional
- Category Large Value
- Investment Style Large Value
- Min. Initial Investment 1M
- Status Open
- TTM Yield 1.83%
- Turnover 49%
USD | NAV as of Jul 21, 2026 | 1-Day Return as of Jul 21, 2026, 12:34 AM GMT+0
Morningstar’s Analysis MDVZX
Will MDVZX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 28.2
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Merck & Co Inc | 4.24 | 6M | Healthcare |
UnitedHealth Group Inc | 3.85 | 5M | Healthcare |
Citigroup Inc | 3.59 | 5M | Financial Services |
ExxonMobil Holdings Corp | 2.71 | 4M | Energy |
Qualcomm Inc | 2.61 | 3M | Technology |
Wells Fargo & Co | 2.52 | 3M | Financial Services |
Gilead Sciences Inc | 2.39 | 3M | Healthcare |
ConocoPhillips | 2.12 | 3M | Energy |
Progressive Corp | 2.08 | 3M | Financial Services |
Bristol-Myers Squibb Co | 2.07 | 3M | Healthcare |